Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries... Show more
In recent trading sessions, Unum Group (UNM) stock has maintained a steady upward trajectory, reflecting investor confidence in its core insurance operations. Shares hover comfortably above key moving averages, supported by a compelling dividend yield of about 2.4% and a forward P/E ratio around 18. The stock's position in the middle of its annual range underscores balanced momentum, bolstered by anticipation surrounding upcoming quarterly results and favorable industry dynamics in group benefits. Broader market cycles have favored financial services names with strong fundamentals, positioning UNM for continued stability amid evolving economic pressures.
Tickeron’s Trending AI Robots page showcases a curated selection of the platform's top-performing AI-driven trading bots, drawn from a library of over 350 bots that analyze and trade thousands of tickers across stocks, ETFs, and crypto. Currently featuring 25 standout performers optimized for prevailing market conditions, these bots display impressive stats: annualized returns ranging from 15% to over 167%, win rates between 48% and 88%, and profit factors up to 11.7. Strategies vary widely— from short-term trend followers on semiconductors like NVDA and AMD (with 1-day holds yielding 100%+ returns) to multi-agent systems on volatile sectors like aerospace and energy, balancing high profit-to-drawdown ratios (up to 21.5) with risk controls like 2-3% take-profit stops. Whether focusing on high-win-rate scalpers or sector-themed portfolios, these tools cater to diverse timeframes and risk appetites. Explore the page to identify bots aligning with your strategy and current opportunities.
Unum Group, a leading provider of workplace benefits including disability, life, and supplemental insurance, has experienced measured price appreciation in recent weeks, supported by key corporate announcements and analyst updates. On April 9, the company declared a quarterly dividend of $0.46 per common share, payable in May, marking a consistent payout that reinforces its shareholder-friendly policy and contributes to a yield near 2.4%. This news aligned with steady trading, as shares climbed roughly 5% over the prior month, reflecting comfort in the company's cash flow generation.
Earlier, on April 6, Unum announced its Q1 2026 results release scheduled for April 28, heightening market focus on operational metrics. Analysts anticipate adjusted operating EPS of approximately $2.06, up year-over-year, alongside revenue around $1.95 billion, fueled by premium growth and improved claims efficiency. Previews highlight potential reserve releases and persistency gains in group life and disability lines, which could drive positive sentiment if met or exceeded. This anticipation has underpinned recent gains, with the stock outperforming peers amid sector rotation toward stable insurers.
Analyst actions further shaped dynamics: Zacks Research upgraded UNM to Hold from Strong Sell on April 8, citing revised earnings estimates including $2.17 for Q2. Conversely, BofA Securities adjusted its price target lower to $77 from $83 while maintaining Neutral on April 14, reflecting caution on valuation post-rally. Despite this, the overall consensus remains Buy from 13 analysts, with an average target of $93.38—suggesting over 20% upside—and recent shelf registration filing on April 23 viewed as routine capital access rather than dilutive.
Macro factors, including stable interest rates supporting net investment income (NII, profits from investment portfolios), and benign claims trends in the insurance sector have provided tailwinds. No major regulatory hurdles or competitive M&A (mergers and acquisitions) disruptions emerged, allowing fundamentals to shine. These elements collectively fostered investor optimism, propelling shares higher while capping volatility ahead of earnings.
As Unum Group advances through 2026, investors should track core growth drivers outlined in its February outlook: 4-7% premium expansion from a $10 billion base, propelled by new business sales and high policy persistency in group benefits. Adjusted operating EPS guidance of $8.60-$8.90 implies 8-12% growth, supported by operational efficiencies and return on equity (ROE, a measure of profitability relative to shareholders' equity) targets above 15%.
Opportunities lie in technology-driven claims processing to curb loss ratios (claims paid relative to premiums) and expanding voluntary benefits amid workplace wellness trends. Risks include macroeconomic slowdowns pressuring employment-related sales, interest rate shifts impacting NII, and competitive pressures from peers like Prudential or Lincoln National. Regulatory scrutiny on disability reserving and potential healthcare reforms warrant attention. Balanced positioning in U.S. and U.K. markets, plus disciplined capital returns (aiming for 100% of earnings via dividends and buybacks), positions Unum favorably, contingent on execution amid evolving industry dynamics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
UNM saw its Momentum Indicator move above the 0 level on May 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for UNM just turned positive on June 05, 2026. Looking at past instances where UNM's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UNM advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 322 cases where UNM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UNM broke above its upper Bollinger Band on June 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UNM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.330) is normal, around the industry mean (1.390). UNM has a moderately high P/E Ratio (19.628) as compared to the industry average of (13.156). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.685). Dividend Yield (0.020) settles around the average of (0.044) among similar stocks. P/S Ratio (1.160) is also within normal values, averaging (1.324).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of long-term and short-term disability insurance, group life and accidental death and dismemberment products
Industry LifeHealthInsurance